Evolving Care of Heavily Treatment–Experienced Patients With HIV

Download All
Learn how to assess and manage challenging case scenarios featuring heavily treatment–experienced patients with HIV with a series of expert discussion videos and slides reviewing the latest data and guidelines.
Roger Bedimo, MD, MS, FACP
Joseph J. Eron, Jr., MD
Monica Gandhi, MD, MPH
Princy N. Kumar, MD, FIDSA, MACP
David A. Wohl, MD
Brian Wood, MD

Video Modules

In this call between colleagues, expert faculty discuss their approaches to assessing virologic failure in a patient with an extensive but incomplete treatment history, including recommendations on assessing adherence and determining which resistance tests are needed.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

In this call between colleagues, expert faculty discuss how they approach ART optimization in a virologically suppressed patient with HIV and multiclass resistance, including a discussion of relevant guidelines and data.

Roger Bedimo, MD, MS, FACP David A. Wohl, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 24, 2021 Expired: March 23, 2022

In this call between colleagues, expert faculty discuss how they select next-line ART for a heavily treatment–experienced patient with multiclass drug resistance experiencing virologic failure; discussion includes current and future options for treating patients with multiclass drug resistance.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 19, 2021 Expired: April 18, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue